Moreover, knockdown of BTRC could increase ATGL levels, inhibit TAG accumulation, and ameliorate hepatic steatosis, suggesting the potential of targeting BTRC for the treatment of NAFLD. Here, BTRC is linked to metabolic dysfunction-associated steatotic liver disease.